Movement Disorders Analysis Using a Deep Learning Approach
1 other identifier
observational
50
1 country
1
Brief Summary
Bradykinesia is a key parkinsonian feature yet subjectively assessed by the MDS-UPDRS score, making reproducible measurements and follow-up challenging. In a Movement Disorder Unit, the investigators acquired a large database of videos showing parkinsonian patients performing Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III protocols. Using a Deep Learning approach on these videos, the investigators aimed to develop a tool to compute an objective score of bradykinesia from the three upper limb tests described in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
July 3, 2021
CompletedFirst Posted
Study publicly available on registry
July 23, 2021
CompletedJuly 23, 2021
July 1, 2021
1.5 years
July 3, 2021
July 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III score
Automatic Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part III for hand bradykinesia including the three following specific tasks (finger tapping, hand movements and pronation-supination movements of hand). The minimum score is 0. The maximum score is 12 Higher scores mean wors outcome
1 day
Eligibility Criteria
All patients seen by a neurologist in the department of Neurology at Avicenne Hospital (Bobigny, France) between June 2019 and December 2020 were recorded during MDS-UPDRS examination. The investigators also included healthy volunteers on a voluntary basis.
You may qualify if:
- Age \> 18 years
You may not qualify if:
- Refusal of participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Avicenne
Bobigny, Seine Saint Denis, 93000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Clément Desjardins, MD
Hospital Avicenne
- STUDY DIRECTOR
Bertrand Degos, MD,PhD
Hospital Avicenne
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurology Resident
Study Record Dates
First Submitted
July 3, 2021
First Posted
July 23, 2021
Study Start
June 1, 2019
Primary Completion
November 18, 2020
Study Completion
December 31, 2020
Last Updated
July 23, 2021
Record last verified: 2021-07